# VitD3 Supplementation in Patients With Multiple Myeloma

> **NCT05846880** · EARLY_PHASE1 · RECRUITING · sponsor: **Amany Keruakous, MD, MS.** · enrollment: 100 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Maintenance Vitamin D
- **DRUG:** No maintenance Vitamin D

## Key facts

- **NCT ID:** NCT05846880
- **Lead sponsor:** Amany Keruakous, MD, MS.
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05846880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05846880, "VitD3 Supplementation in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05846880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*